Newsfeeds Archive - Page 4 of 5

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

November 7, 8:37 AM

Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings came out 2 days ago.

ATNX

23 minute read

News
Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

October 24, 11:41 AM

On Monday, 413 companies reached new 52-week lows.

AAN

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

October 18, 8:24 AM

Gainers Akouos (NASDAQ:AKUS) shares moved upwards by 86.2% to $13.05 during Tuesday's pre-market session. The company's market cap stands at $481.5 million.

AKLI

30 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

October 12, 1:32 PM

During Wednesday's trading, 517 companies set new 52-week lows.

$APE

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

September 27, 5:44 PM

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.

ANPC

1 minute read

HC Wainwright & Co. Maintains Buy on Benitec Biopharma, Lowers Price Target to $4

By Benzinga Newsdesk

September 23, 6:48 AM

HC Wainwright & Co. analyst Patrick Trucchio maintains Benitec Biopharma (NASDAQ:BNTC) with a Buy and lowers the price target from $10 to $4.

BNTC

24 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

September 19, 12:30 PM

On Monday, 429 stocks made new 52-week lows.

ADCT

29 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

September 16, 2:08 PM

During Friday's session, 574 stocks hit new 52-week lows.

ACCO

6 minute read

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday

By Lisa Levin

September 14, 3:58 AM

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.

AAPL